As the primary caregiver, Kara Deschenes life was dramatically shaken following her husband's diagnosis with prostate cancer. In dealing with the stress associated with the situation, she learned to use healthy channels to balance her feelings.
Study of Immunotherapy to Treat Advanced Prostate Cancer
BMS is conducting a Phase 3 trial using a novel immunotherapy agent in patients with metastatic CRPC that have received prior treatment with docetaxel. Ipilimumab (anti CTLA-4) plus radiotherapy will be compared to placebo plus radiotherapy in this study, to determine if ipilimumab prolongs survival in men who have metastatic CRPC.